Evidence map›Paper›PMID 40063697›Full record

ArticleJournal of neuropathology and experimental neurology2025

Correlating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer's disease and related neurodegenerative pathologies using 7T postmortem MRI.

Jr-Jiun Liou, Jinghang Li, Jacob Berardinelli, Hecheng Jin, Tales Santini, Jaehoon Noh, Nadim Farhat, Minjie Wu, Howard J Aizenstein, Joseph M Mettenburg and 6 more

Abstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Bridging Neuroimaging and Neuropathology: A Comprehensive Workflow for Targeted Sampling of White Matter Lesions.Journal of neuroimaging : official journal of the American Society of Neuroimaging
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Jr-Jiun LiouDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.ORCID 0000-0002-8800-9557
Jinghang LiDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Jacob BerardinelliDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Hecheng JinDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Tales SantiniDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Jaehoon NohDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA, United States.
Nadim FarhatDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Minjie WuDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, United States.
Howard J AizensteinDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, United States.
Joseph M MettenburgDepartment of Radiology, University of Pittsburgh, Pittsburgh, PA, United States.
William H YongDepartment of Pathology & Laboratory Medicine, University of California Irvine, Irvine, CA, United States.
Elizabeth HeadDepartment of Pathology & Laboratory Medicine, University of California Irvine, Irvine, CA, United States.
Milos D IkonomovicDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
Tamer S IbrahimDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
Julia K KoflerDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA, United States.ORCID 0000-0003-4298-7328
Alzheimer Biomarker Consortium—Down Syndrome

Funding

Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTIAN, BRADLEY T, HANDEN, BENJAMIN L · 2020 to 2025
$103.7M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN · 2020 to 2026
$29.4M
The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Crystal M. Glover · 2020 to 2026
$27.9M
Biomarkers of Alzheimer's Disease in Adults with Down SyndromeU01AG051412 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LOTT, IRA T., SCHUPF, NICOLE · 2015 to 2019
$26.3M
NiAD Supplement WashU Start UpU01AG051406 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HANDEN, BENJAMIN L, TOGA, ARTHUR W · 2015 to 2019
$21.3M
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's DiseaseR01AG063525 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, COHEN, ANN D. · 2019 to 2023
$3.7M
High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with DepressionR01MH111265 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, IBRAHIM, TAMER S · 2016 to 2020
$3.6M
Genetic and molecular correlates of white matter pathology in Alzheimers diseaseR01AG069912 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOFLER, JULIA K · 2021 to 2025
$2.8M
Bioengineering in Psychiatry Training ProgramT32MH119168 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, IBRAHIM, TAMER S · 2019 to 2023
$1.1M
Alzheimer Disease Biomarker ConsortiumAlzheimer Disease Biomarker Consortium on Down syndromeBioengineering in Psychiatry Training T32MH119168Eunice Kennedy Shriver National Institute of Child Health and Human Development U01AG051406National Institute of Child Health and Human Development U01AG051406NIA NIH HHS P30 AG066468NIA NIH HHS P30 AG066519NIA NIH HHS R01 AG063525NIA NIH HHS R01 AG069912NIA NIH HHS U01 AG051406NIA NIH HHS U01 AG051412NIA NIH HHS U19 AG068054NIH HHS R01AG063525NIMH NIH HHS R01 MH111265NIMH NIH HHS T32 MH119168NSF OAC-2117681University of Pittsburgh Center for Research Computing
6 · The paper itself

Abstract

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC), is common in elderly brains and often seen in conjunction with Alzheimer's disease neuropathologic change (ADNC). LATE-NC typically begins in the amygdala and spreads to the hippocampus and neocortex. Whether it contributes to hippocampal and amygdala atrophy in Down syndrome (DS) remains unexplored. We analyzed amygdala and hippocampal volumes and neuropathological burden in 12 DS cases and 54 non-DS cases with AD and related neurodegenerative pathologies (ADRNP) using 7 Tesla (7T) postmortem ex vivo MRI. Postmortem and antemortem hippocampal volumes were significantly correlated in a subset of 17 cases with available antemortem MRI scans. DS cases had smaller hippocampal and amygdala volumes than ADRNP cases; these correlated with more severe Braak stage but not with Thal phase. LATE-NC and hippocampal sclerosis (HS) were uncommon in DS cases. In ADRNP cases, lower hippocampal volumes associated with dementia duration, advanced Thal phase, Braak NFT stage, C score, LATE-NC stage, HS and arteriolosclerosis severity; reduced amygdala volumes correlated with severe LATE-NC stage, HS, and arteriolosclerosis severity, but not with Thal phase or Braak NFT stage. Lewy body pathology did not affect hippocampal or amygdala volume in either cohort. Thus, hippocampal volumes in ADRNP were influenced by both ADNC and LATE-NC, and amygdala volumes were primarily influenced by LATE-NC. In DS, hippocampal and amygdala volumes were primarily influenced by tau pathology.

Indexed as

Alzheimer DiseaseAmygdalaDown SyndromeHippocampusNeurodegenerative DiseasesAdultAgedAged, 80 and overAutopsyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedOrgan SizePostmortem ImagingAlzheimer diseaseamygdalaDown syndromehippocampuspostmortem imaging

Identifiers

PMID40063697
PMCPMC12012357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.